Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran.
Department of Medical Microbiology and Parasitology, Faculty of Medicine and Health Sciences, University of Putra, Malaysia.
Iran J Basic Med Sci. 2014 Jan;17(1):21-6.
OBJECTIVE(S): To date, the most important genes responsible for tetracycline resistance among Acinetobacter baumannii isolates have been identified as tet A and tet B. This study was carried out to determine the rate of resistance to tetracycline and related antibiotics, and mechanisms of resistance.
During the years 2010 and 2011, a total of 100 A. baumannii isolates were recovered from patients in different hospitals of Tehran, Iran. Antimicrobial susceptibility to tetracycline, minocycline, doxicycline and tigecycline was evaluated by E-test. Polymerase chain reaction (PCR) of the tet A and tet B genes was performed using specific primers, after which the isolates were subjected to Repetitive Extragenic Palindromic-PCR (PCR) to identify the major genotypes.
Of all isolates, 89% were resistant to tetracycline (MIC50 = 32 µg/ml, MIC90 = 512 µg/ml). Minocycline with the resistant rate of 35% (MIC50 = 16 µg/ml, MIC90 =32 µg/ml) and doxicycline with the resistant rate of 25% (MIC50 = 16 µg/ml, MIC90= 32 µg/ml) have a good activity against A. baumannii isolates. All isolates were sensitive to tigecycline. Frequencies of tet B and tet A genes and coexistence of tet A and tet B among the isolates resistant to tetracycline, were 87.6%, 2.2% and 1.1%, respectively. Distribution of REP-types among A. baumannii isolates was types A (40%), B (30%), C (10%), D (5%) and E (5%).
It seems that tet A and tet B genes play an important role in the induction of resistance towards tetracyclines used in this study. It is suggested that further studies focus on other antimicrobial drugs and combinations in order to achieve a successful therapy against multi drug resistance (MDR) A. baumannii strains in Iran.
迄今为止,鲍曼不动杆菌分离株中与四环素耐药相关的最重要基因已被鉴定为 tetA 和 tetB。本研究旨在确定对四环素和相关抗生素的耐药率以及耐药机制。
2010 年至 2011 年,从伊朗德黑兰不同医院的患者中共分离出 100 株鲍曼不动杆菌。采用 E 试验法评估四环素、米诺环素、多西环素和替加环素的药敏性。采用特异性引物对 tetA 和 tetB 基因进行聚合酶链反应(PCR),然后对分离株进行重复外回文 PCR(PCR)以鉴定主要基因型。
所有分离株中,89%对四环素耐药(MIC50=32μg/ml,MIC90=512μg/ml)。米诺环素的耐药率为 35%(MIC50=16μg/ml,MIC90=32μg/ml),多西环素的耐药率为 25%(MIC50=16μg/ml,MIC90=32μg/ml),对鲍曼不动杆菌分离株具有良好的活性。所有分离株均对替加环素敏感。四环素耐药分离株中 tetB 和 tetA 基因的频率分别为 87.6%、2.2%和 1.1%,tetA 和 tetB 同时存在的频率为 1.1%。鲍曼不动杆菌分离株的 REP 型分布为 A 型(40%)、B 型(30%)、C 型(10%)、D 型(5%)和 E 型(5%)。
tetA 和 tetB 基因似乎在诱导本研究中使用的四环素耐药中起重要作用。建议进一步研究其他抗菌药物和联合用药,以实现对伊朗多药耐药(MDR)鲍曼不动杆菌菌株的成功治疗。